Shuttle Pharmaceuticals Awarded New HDAC Inhibitor Patents for Cancer Treatment
/PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company, announced today that...
Source: prnewswire.com